Boardroom Alpha
Boardroom Alpha
FGI · Current Report (Form 8-K) · Filed July 29, 2025

Fgi Industries Ltd — Current Report (Form 8-K)

Form
8-K
Filed
July 29, 2025
Period
Jul 28, 2025
Ticker
FGI
Accession
0001628280-25-036293
Boardroom Alpha · Filing insights

FGI Industries to implement a 1-for-5 reverse stock split effective July 31, 2025; fractional shares cashed and warrants and options adjusted.

About Fgi Industries Ltd
Market cap
$11M
1Y TSR
+88.4%
3Y TSR
−11.6%
Board grade
B-
Sector
Consumer Cyclical
CEO
David E Bruce
Last annual meeting: Jun 3, 2026 · View full Fgi Industries Ltd profile →
fgi-20250728

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
____________________________________________________
FORM 8-K
____________________________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): July 28, 2025
____________________________________________________
FGI Industries Ltd.
(Exact name of registrant as specified in its charter)
____________________________________________________
Cayman Islands001-4120798-1603252
(State or other jurisdiction of
incorporation)
(Commission
File Number)
(I.R.S. Employer
Identification No.)
906 Murray Road
East Hanover, NJ 07936
(Address of principal executive offices) (Zip Code)
(973) 428-0400
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
____________________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)
Name of each exchange
on which registered
Ordinary Shares, $0.0001 par value per shareFGIThe Nasdaq Stock Market LLC
Warrants to purchase Ordinary SharesFGIWWThe Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company x
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o



Item 3.03    Material Modification to Rights of Security Holders.
To the extent required by Item 3.03 of Form 8-K, the information contained in Item 5.03 of this Current Report is incorporated herein by reference.
Item 5.03    Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
On July 28, 2025, FGI Industries Ltd. (the “Company”) filed an amendment (the “Amendment”) to the Company’s Amended and Restated Memorandum and Articles of Association with the Registrar of Companies in the Cayman Islands to effect a 1-for-5 reverse share split (the “Reverse Share Split”) of the Company’s ordinary shares, par value $0.0001 per share (“Ordinary Shares”). Pursuant to the Amendment, effective as of 12:01 a.m., Eastern Time, on July 31, 2025 (the “Effective Time”), every 5 Ordinary Shares issued and outstanding, including Ordinary Shares held by the Company as treasury shares, will be automatically combined into one Ordinary Share. As a result of the Reverse Share Split, the par value of the Company’s Ordinary Shares will go from $0.0001 per share to $0.0005 per share. As of April 24, 2025, the Company had 9,591,555 Ordinary Shares issued and outstanding. The Company’s shareholders of record will receive a cash payment (without interest) in lieu of any fractional shares they would have otherwise been entitled to receive in the Reverse Share Split.
The Ordinary Shares are expected to begin trading on The Nasdaq Capital Market on a split-adjusted basis at the opening of trading on July 31, 2025. The Common Stock will continue trading on The Nasdaq Capital Market under the symbol “FGI” with a new CUSIP number (G3302D202). The Company’s publicly traded warrants will continue to be traded on The Nasdaq Capital Market under the symbol “FGIWW” and the CUSIP number for the public warrants will remain unchanged. However, under the terms of the applicable warrant agreement the number of Ordinary Shares issuable on exercise of each warrant will be proportionately decreased. Specifically, following effectiveness of the Reverse Share Split, every 5 Ordinary Shares that may be purchased pursuant to the exercise of the warrants will represent one Ordinary Share that may be purchased pursuant to such warrants. Accordingly, for the Company’s warrants trading under the symbol “FGIWW”, every 5 warrants will be exercisable for one Ordinary Share at an exercise price of $30.00 per Ordinary Share.
As of the Effective Time, the number of Ordinary Shares available for issuance under the Company’s equity incentive plans and issuable pursuant to equity awards immediately prior to the Reverse Share Split will be proportionately adjusted by the Reverse Share Split. The exercise prices of the Company’s outstanding options and equity awards will be adjusted in accordance with their respective terms.
The Reverse Share Split will affect all record holders of the Ordinary Shares uniformly and will not affect any record holder’s percentage ownership interest in the Company, except for de minimis changes as a result of the elimination of fractional shares. Holders of Ordinary Shares who hold in “street name” in their brokerage accounts do not have to take any action as a result of the Reverse Share Split. Their accounts will be automatically adjusted to reflect the number of shares owned.
The foregoing description of the Amendment is qualified in its entirety by reference to the Amendment, a copy of which is filed as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated herein by reference.
Item 9.01.   Financial Statements and Exhibits.
(d)Exhibits
The following exhibits are filed herewith:
Exhibit
NumberDescription
3.1
104Cover Page Interactive Data File (embedded within the Inline XBRL document)



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
FGI Industries Ltd.
 
 
Dated: July 29, 2025By:/s/ John Chen
John Chen
Executive Chairman

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Fgi Industries Ltd (FGI)

Reference

Frequently asked questions

When did Fgi Industries Ltd file this 8-K?
Fgi Industries Ltd (FGI) filed this Current Report (Form 8-K) with the SEC on July 29, 2025. The accession number assigned by EDGAR is 0001628280-25-036293.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
FGI Industries to implement a 1-for-5 reverse stock split effective July 31, 2025; fractional shares cashed and warrants and options adjusted. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Fgi Industries Ltd's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Fgi Industries Ltd has filed under CIK 1864943, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer